Research Article
Intramuscular Olanzapine in the Management of Behavioral and Psychological Symptoms in Hospitalized Older Adults: A Retrospective Descriptive Study
Table 3
Documented adverse events and monitoring among cases that received olanzapine IM.
| Adverse event | Number (%) |
| Sedation | 7 (20.6%) | Orthostatic hypotension | 5 (14.7%) | Falls | 4 (11.8%) | Decreased level of consciousness | 4 (11.8%) | Extrapyramidal symptoms | 3 (8.8%) | Weakness | 1 (2.9%) | Monitoring of vital signs (within 6 hrs) | | Complete monitoring | 42 (33.9%) | Incomplete monitoring | 10 (8.1%) | No monitoring documented | 58 (46.8%) | Patient refuses to comply | 14 (11.2%) |
|
|